- Home page | CEPI
CEPI, the Coalition for Epidemic Preparedness Innovations, is a global partnership working to accelerate the development of vaccines and other biologic countermeasures against epidemic and pandemic threats
- About CEPI | CEPI
CEPI leverages its unique position within the global health and R D ecosystems, building on its proven track record of bringing together public-sector, private-sector and academic partners to accelerate the development of vaccines against emerging viral threats
- Global Pandemic Preparedness Summit | CEPI
On July 29-30, 2024, The Ministry of Health, Brazil, Fundação Oswaldo Cruz , and the Coalition for Epidemic Preparedness Innovations (CEPI) hosted The Global Pandemic Preparedness Summit 2024 The Summit aimed to reinvigorate momentum for pandemic preparedness and response—helping to ensure that we can end future infectious disease
- Calls for Proposals - CEPI
If you would like to get a broader understanding of a CEPI Call for Proposal and or see if your idea, project, technology, or approach meets our suitability and eligibility requirements, ahead of filling out your application or getting involved with CEPI, we can organise a “CEPI Tech Talk”
- Our portfolio - CEPI
Our interactive portfolio provides information on each of the vaccine candidates that CEPI has invested in as well as our Centralised Lab Network, Preclinical Models and Vaccine Manufacturing Network partners
- CEPI 2. 0 and the 100 Days Mission
CEPI’s 2022-2026 strategy, known as CEPI 2 0, is helping to Prepare, Transform, and Connect the world so that it can respond to the next Disease X by accelerating the development of safe, effective, globally accessible vaccines in as little as 100 days
- Call for Proposals Focus Area 1: Innovative vaccine platforms . . . - CEPI
CEPI invites proposals to advance vaccine platforms through Phase I proof of concept Developers with very early-stage technologies can apply for an Exploratory Award of up to US $1M over a
- Bringing together all pieces of the Lassa fever vaccine puzzle | CEPI
2024 saw great progress in developing the world’s first Lassa fever vaccine, with a CEPI-funded vaccine candidate entering Phase II trials in West Africa Now, CEPI is working alongside regional partners to speed up the path to licensure and enable equitable access to future doses
|